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Abstract
Background: Wnt signaling controls the balance between stem cell proliferation and differentiation and body patterning
throughout development. Previous data demonstrated that non-canonical Wnts (Wnt5a, Wnt11) increased cardiac gene
expression of circulating endothelial progenitor cells (EPC) and bone marrow-derived stem cells cultured in vitro. Since
previous studies suggested a contribution of the protein kinase C (PKC) family to the Wnt5a-induced signalling, we
investigated which PKC isoforms are activated by non-canonical Wnt5a in human EPC.
Methodology/Principal Findings: Immunoblot experiments demonstrated that Wnt5a selectively activated the novel PKC
isoform, PKC delta, as evidenced by phosphorylation and translocation. In contrast, the classical Ca
2+-dependent PKC
isoforms, PKC alpha and beta2, and one of the other novel PKC isoforms, PKC epsilon, were not activated by Wnt5a. The PKC
delta inhibitor rottlerin significantly blocked co-culture-induced cardiac differentiation in vitro, whereas inhibitors directed
against the classical Ca
2+-dependent PKC isoforms or a PKC epsilon-inhibitory peptide did not block cardiac differentiation.
In accordance, EPC derived from PKC delta heterozygous mice exhibited a significant reduction of Wnt5a-induced cardiac
gene expression compared to wild type mice derived EPC.
Conclusions/Significance: These data indicate that Wnt5a enhances cardiac gene expressions of EPC via an activation of
PKC delta.
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Introduction
Various different types of adult stem or progenitor cells were
shown to express cardiac genes and acquire a cardiac phenotype,
when exposed to a cardiogenic environment. However, the
incidence of cardiac differentiation is rather low in several studies,
and it is unclear to what extent a fully functional maturation can
be achieved. Therefore, the elucidation of signaling pathways
controlling cardiac differentiation is of major importance to
improve cardiac gene expression and functional maturation.
Wnt proteins are well known as crucial signaling molecules
involved in physiological development [1], cancer development, as
well as decision of stem cell fate [2]. Wnts play an important role
for self renewal of hematopoietic stem cells [3] and maintenance of
pluripotency of mouse embryonic stem cells [4]. Wnt5a promotes
epithelial-to-mesenchymal transition in a melanoma cell line [5].
With respect to cardiovascular development and differentiation,
both canonical and non-canonical Wnt signalings are important
regulators. Inhibition of canonical Wnt signaling induces heart
formation [6]. On the other hand, canonical Wnt signaling via
GSK3b and b-catenin contributed to cardiac differentiation of
mouse P19 cells [7], and Isl1
+ cardiac progenitors [8]. For cardiac
differentiation of embryonic stem cells, canonical Wnt/ß-catenin
signaling is essential during early stages, but it inhibits cardiogen-
esis at later time points [9]. Non-canonical Wnts comprise Wnt-4,
-5 and -11. As shown in model organisms, Wnt-11 stimulates
cardiogenesis [10]. Moreover, Wnt-11 was shown to increase
cardiac gene expressions in EPC and bone marrow derived
mesenchymal stem cells [11,12], and Wnt-11 induced cardiomyo-
genic differentiation in unfractionated bone marrow mononuclear
cells [13]. Non-canonical Wnt signaling also enhances differenti-
ation of Sca1
+/c-kit
+ adipose-derived murine stromal cells into
spontaneously beating cardiomyocytes [14]. These data suggest
that non-canonical Wnts such as Wnt5a and Wnt11 might be
interesting candidates to enhance cardiac gene expression in adult
progenitor cells.
In contrast to the well defined ß-catenin-dependent canonical
Wnt signaling, the pathways mediating non-canonical Wnt
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Wnt pathways were proposed, including calcium-dependent
signaling, the planner cell polarity (PCP) pathway via activation
of the Rho kinase, activation of the c-Jun N-terminal kinase (JNK),
or protein kinase C (PKC) [15]. With respect to cardiac
differentiation in adult progenitor cells, several studies showed
that non-canonical Wnts induce cardiac gene expression in a
PKC-dependent manner [11–13]. However, the PKC isoforms
have not been identified.
Using both, pharmacological inhibitor as well as genetic
ablation in vivo, we identify the novel PKC isoform, PKC delta,
to importantly contribute to cardiac gene expression in EPC,
indicating that PKC delta is a key target of the non-canonical Wnt
pathway.
Results
Addition of Wnt5a increased cardiac gene expression
First, we investigated the effect of two different doses of Wnt5a
(100 ng/ml and 1 mg/ml) on cardiac gene expression of EPC co-
cultured with neonatal rat CMs. Wnt5a at a concentration of
1 mg/ml significantly increased the number of cells positive for
human HLA and alpha-sarcomeric actinin, which represent
human cells expressing cardiac genes (Fig. 1A/B). The enhance-
ment of cardiac gene expression was further confirmed by RT-
PCR using human-specific primers selectively detecting human
troponin T and human alpha-myosin heavy chain. The mRNA-
expression of both genes was increased by Wnt5a treatment
(Fig. 1C/D). To confirm that the PCR product indeed represents
human troponinT, we sub-cloned the human-troponin T PCR
products using pGEM-Teasy vector and analyzed the sequences.
Sequences were 100% identical to human troponin T (supple-
mentary figure S1A).
Wnt5a activates PKC delta but not PKC epsilon
According to our previous data, cardiac gene expression in EPC
was inhibited by pan-PKC inhibitors, Bisindolylmaleimide I and
Bisindolylmaleimide III [11], whereas the PKC activator phorbol-
12-myristate-13-acetate (PMA) increased cardiac gene expression
[11]. These data excluded the involvement of PMA-independent
atypical PKC isoforms. Therefore, we investigated the potential
involvement of calcium-dependent classical PKC or novel PKC
isoforms to mediate Wnt5a-induced increases of cardiac gene
expression. First, we investigated which PKC isoforms are
activated by Wnt5a in EPC. Since pan phospho-PKC was
increased 30 minutes after incubation with Wnt5a (Fig. 2A), we
stimulated cells with Wnt5a for 30 minutes. As shown in figure 2B,
phosphorylation of PKC delta, which is a novel PKC isoform, was
Figure 1. Wnt5a increased cardiac differentiation of EPC. EPCs were co-cultured with rat cardiomyocytes and analyzed after 6 days. (A)
Representative flow cytometry analysis using human HLA and alpha sarcomeric actinin. (B) Summary of dose dependent Wnt5a (100 ng/ml or 1 mg/
ml) effects on human HLA and alpha sarcomeric actinin double positive cells. n=5. * indicates p,0.05 vs control. (C/D). RT-PCR images of human
specific troponin T (hTnT), alpha myosin heavy chain (h-aMHC), or GAPDH in control or Wnt5a treated cells.
doi:10.1371/journal.pone.0005765.g001
PKCd on EPC Differentiation
PLoS ONE | www.plosone.org 2 June 2009 | Volume 4 | Issue 6 | e5765PKCd on EPC Differentiation
PLoS ONE | www.plosone.org 3 June 2009 | Volume 4 | Issue 6 | e5765significantly increased by Wnt5a, whereas phosphorylation of
another novel PKC, PKC epsilon, and the calcium-dependent
classical PKCs (PKC alpha and beta2) did not change (Fig. 2B/C).
These data suggested that PKC delta appears to be selectively
activated by Wnt5a. In order to corroborate the selectively
activation of PKC delta by Wnt5a, we examined the translocation
of PKC delta and PKC epsilon to the triton X-insoluble fraction.
Since total PKC delta level was high in the triton X-soluble and -
insoluble fraction without stimulation of Wnt5a (data not shown),
we decided to use phospho-PKC delta antibodies to detect the
active form of PKC delta. Phosphorylation of PKC delta was only
detected in the triton X-insoluble fraction after treatment with
Wnt5a, indicating that the active form of PKC delta was present in
the cytoskeleton (triton X-insoluble) fraction (Fig. 2D). In
accordance, immunochemistry revealed that phospho-PKC delta
can be detected in association with the membrane and cytoskelton
(Fig. 2E). Interestingly, only 30 minutes stimulation with Wnt5a,
the morphology of EPCs was clearly changed (Fig. 2E). Taken
together, these data indicate that Wnt5a selectively activates the
PKC delta isoform in EPC.
Cardiac gene expression is attenuated by inhibition of
PKC delta
Finally, we determined the role of PKC delta for EPC cardiac
gene expression. Incubation with the relatively selective PKC delta
inhibitor, rottlerin (1 mM), significantly attenuated cardiac differ-
entiation (Fig. 3A). Importantly, increased cardiac marker gene
expression by Wnt5a was also inhibited by rottlerin, suggesting
that PKC delta is an important mediator for cardiac gene
expression via non-canonical Wnt signaling. In contrast to the
effect of PKC delta inhibition, PKC epsilon inhibition had no
effect on cardiac gene expression (Fig. 3B). Surprisingly,
incubation with the calcium-dependent PKC inhibitor, Go ¨6976,
also increased cardiac gene expression (Fig. 3C). Go ¨ 6976 also
enhanced phosphorylation of PKC delta (Fig. 3D), suggesting that
inhibition of the calcium-dependent PKC by Go ¨6976 is paralleled
by an activation of PKC delta, which was likely contributing to
increased cardiac gene expression.
In order to avoid potential unspecific effects of pharmacological
PKC delta inhibition, we isolated EPC from the spleen of PKC
delta deficient mice or wild type mice. Before investigating the
cardiac differentiation capacity of splenic EPC, we characterized
the mononuclear cells isolated from spleen in PKC delta 2/2
mice, PKC delta +/2 mice, and wild type mice. The spleen size
and several subsets of progenitor cell numbers (CD45
+/c-kit
+ cells
and CD45
+/sca-1
+/c-kit
+ cells) were significantly increased in
PKC delta 2/2, but not PKC delta +/2 mice (Fig. 4AB).
Furthermore, Wnt5a treatment significantly increased EPC
number in PKC delta 2/2 mice, but had no effect on EPC
numbers when EPC had been isolated of PKC delta +/2 mice
(data not shown). Since the characteristic and number of PKC
delta 2/2 EPC is different from wild type or PKC delta +/2
EPC, we purposely used spleen-derived EPC from PKC delta +/2
mice, which showed normal hematopoietic stem cell numbers to
perform the co-culture assay with neonatal rat CM. Wnt5a
treatment only increased cardiac differentiation in EPC isolated
from wild type mice, but not in EPC isolated from PKC delta +/2
mice (Fig. 4C).
Discussion
Both canonical and non-canonical Wnt signaling were shown to
be important for cardiovascular development and differentiation.
In particular, non-canonical Wnt pathways play a crucial role in
cardiogenesis [10]. Protein kinase C is one of the key targets of
non-canonical Wnt signaling. The importance of the Wnt/PKC
pathway for cardiac gene expression was previously demonstrated
in several adult stem cells [11–13] by using spontaneous
differentiation assay [13] and co-culture systems [11,12,19]. We
used a co-culture assay with rat CMs to mimic the cardiac
environment in vitro in this study, because this assay is established
and suitable to assess cardiac gene expression and the underlying
signaling in EPC [12,20–22]. The major finding of the present
study is that a novel PKC isoform, PKC delta, is selectively
activated by non-canonical Wnt5a and contributes to cardiac gene
expression.
Protein kinase C is subdivided into 3 different groups: calcium-
dependent diacylglycerol (DAG)-activated classical PKC (e.g.
alpha, beta1, and beta2), calcium-independent DAG-activated
novel PKC (e.g. delta and epsilon), and calcium-independent
DAG-non-resposive atypical PKC (e.g. zeta and iota). Several
PKC isoforms were reported to be activated in cellular
differentiation processes. PKC epsilon isoform regulates the
megakaryocytic differentiation of human CD34 cells [16] and
induces astrocytic differentiation of neural precursor cells [17].
Differentiation of embryonic stem cells into beating cardiomyo-
cytes is dependent on downregulation of PKC beta and zeta in
concert with upregulation of PKC epsilon [18]. However, the role
of PKC isoforms for cardiac differentiation in adult stem cells has
not been well elucidated. Our data are the first to demonstrate the
contribution of the PKC delta isoform to non-canonical Wnt
signaling induced cardiac differentiation of adult progenitor cells.
PKC delta is a serine/threonine kinase and has important roles
in growth regulation, tissue remodeling [19] and apoptosis [20].
PKC delta deficient mice develop almost normally and are fertile,
but show abnormalities of the immune system [21]. In particular,
PKC delta2/2 mice have increased proliferation of B lympho-
cytes and lymphocytic organ infiltration [21]. Indeed, in the
present study, we observed increases in spleen size and in the
number of myeloid progenitor cell fractions (c-kit
+ cells and sca-
1
+c-kit
+ cells in CD45 fraction) within the splenic mononuclear cell
population in PKC delta 2/2 mice (Fig. 4A/B). The increased
number of sca-1
+c-kit
+ cells may be a consequence of a negative
feedback of dysfunction of progenitor or stem cells in PKC delta-
deficient mice. Therefore, in order to exclude any confounding
secondary effects, we purposely used spleen-derived EPC from
heterozygote mice, which showed normal hematopoietic stem cell
numbers. Consistent with the data using pharmacological
inhibitors, EPC derived from PKC delta +/2 mice exhibited a
reduced capacity to differentiate to CMs upon co-culture with
neonatal CMs. Thus, these data suggest that PKC delta
importantly contributes to cardiac differentiation of adult
progenitor cells.
Figure 2. PKC activation by Wnt5a. PBS or Wnt5a (1 mg/ml) was incubated for 30 minutes in all experiments. (A) Time dependent
phosphorylation of pan-PKC after treatment with Wnt5a (1 mg/ml). (B) Representative phospho-PKC delta (p-PKCd), PKCdelta (PKCd), phospho-PKC
epsilon (p-PKCe), and PKCepsilon (PKCe) and summaries of the quantification are shown. n=3. (C) Representative phospho-PKC alpha/beta2,
PKCalpha, PKCbeta2, and summary of data are shown. n=3. (D) Translocations of phospho-PKC delta and PKC epsilon. Representative immunoblots
of triton soluble and insoluble fractions are shown. n=3–4. (E) Immunochemistry of phospho-PKC delta. Green indicates phospho-PKC delta. Red
indicates nuclei.
doi:10.1371/journal.pone.0005765.g002
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delta signaling remain unclear. Preliminary experiments demon-
strate that Wnt5a induces the gene expression of several epigenetic
modulators, but does not directly increase sarcomeric proteins or
endothelial proteins (RT-PCR, data not shown), suggesting that
Wnt5a does not directly increase cardiac or endothelial gene
expression but facilitates differentiation by modulation of the
epigenetic control pathways. This notion is further supported by
the finding that Wnt5a does not induce cardiac differentiation in
EPC without co-culture with cardiomyocytes indicating that
factors secreted by the neonatal myocytes or cell-to-cell contact
are required in addition to non-canonical Wnt activation to induce
cardiac marker gene expression. Further experiments are
necessary to address this question.
In summary, our data identify PKC delta as a key target of the
non-canonical Wnt signaling pathway contributing to cardiac gene
expressions in EPC.
Materials and Methods
Cell Culture Experiments
EPCs were cultivated from human peripheral blood mononuclear
cells as described [22]. In brief, total mononuclear cells (MNCs) were
isolated from blood by density gradient centrifugation with Biocoll
Figure 3. The effects of pharmacological PKC inhibitors on cardiac differentiation and phosphorylation. (A–C) EPCs from human
peripheral blood were co-cultured with rat cardiomyocytes (CM) and analyzed after 6 days. (A) Summary of cardiac differentiation which are
demonstrated by flow cytometry analysis. Human HLA and alpha sarcomeric actinin double positive cells were counted. Wnt5a (1 mg/ml) or PKC delta
inhibitor, rottlerin (1 mM) were used. * indicates p,0.05 vs control without Wnt5a and rottlerin. # indicates p,0.05 vs Wnt5a without rottlerin. n=5–
7. (B/C) PKC epsilon inhibitory peptide (B) or classical PKC inhibitor (C; Go ¨ 6976) were used. * indicates p,0.05 vs control. n=5–6. (D) Phosphorylation
of PKC delta in control (PBS) and Go ¨ 6976 treatment (both 30 min.) are shown. PKC delta served as control.
doi:10.1371/journal.pone.0005765.g003
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basal medium (EBM) (CellSystems), with supplements (1 mg/ml
hydrocortisone, 3 mg/ml bovine brain extract, 30 mg/ml gentamicin,
50 mg/mlamphotericinB,10 mg/mlEGF), and 20%fetal calfserum
onculturedishescoatedwithhumanfibronectin(Sigma).After3days
in culture, adherent cells were used for experiments. Neonatal
ventricular cardiomyocytes were isolated from 0–1 day old Wistar
rats and cultivated as previously described [11]. Noncardiomyocytes
(primarily fibroblasts) were separated from the cardiomyocytes by
differential plating onto plastic dishes. Then EPCs (1.5610
5)a n d
freshly isolated cardiomyocytes were plated onto gelatine coated
dishes at a ratio of 1:3. Medium was changed every 2 days.
Recombinant mouse Wnt5a (1 mg/ml, R&D) was used to stimulate
cells. For the inhibitory assay, rottlerin (1 mM, Calbiochem), PKC
epsilon translocation inhibitor peptide and its control peptide (both
25 mM, Calbiochem), or Go ¨6976 (100 nM, Calbiochem) were used.
Mice mononuclear cells were isolated by density gradient
centrifugation from spleen extracts as described [23]. 12–16 week
SV129 mice or PKC delta heterozygous (+/2), and homozygous
(2/2) deficient mice were used [24]. Isolated mononuclear cells
were plated in the same medium as human cells.
Flow cytometry analysis and immunostaining
After 6 days of the co-culture, cells were stained with
phycoerythrin-conjugated antibodies recognizing human HLA-
DR and HLA-class I (both Caltag Laboratories), or mouse MHC
class I (H-2K
b, BD) followed by permeabilization using the
Cytofix/Cytoperm kit (BD Pharmingen) and staining with FITC-
conjugated (Pierce) anti-a-sarcomeric actinin antibody (clone EA-
53, Sigma) as descrived [12,19]. Cells were analyzed on a BD
FACS Calibur cell sorter or BD FACS Canto (both BD
Biosciences).
Figure 4. The characteristics and the effects of EPC isolated from PKC deficient mice. (A) Spleen weight per body weight in wild type (WT),
PKC delta +/2, and PKC delta 2/2 mice. * indicates p,0.05 vs wild type mice. n=3–4. (B) CD45+/Sca-1+/c-kit+ cells and CD45+/ c-kit+ cells in splenic
mononuclear cells are shown. * indicates p,0.05 vs wild type mice. n=3–4. (C) Mice EPC from wild type mice and PKC delta +/– mice were isolated
from spleen and used for co-culture with rat cardiomyocytes with or without treatment with Wnt5a. Mouse MHC class I, H-2K
b was quantified by flow
cytometry. n=3–4.
doi:10.1371/journal.pone.0005765.g004
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hyde for 15 minutes. After permeabilization with 0.2% saponin
(Sigma), cells were incubated with anti-phospho-PKC delta (Santa
Cruz), followed by staining with Alexa Flour 488 anti-goat IgG
(Molecular Probes). Nuclei were counterstained with DAPI
according to manufacture protocol.
Immunoblot Analysis
After stimulation with Wnt5a (1 mg/ml, 30 minutes, 1 hour,
2 hours), Go ¨ 6976 (100 nM, 30 minutes), and/or rottlerin (1 mM),
EPC was lysed with lysis buffer (Cell Signaling) containing 1 mM
phenylmethanesulfonyl fluoride. After centrifugation the superna-
tants were collected and subjected to electrophoresis in 10% SDS-
polyacrylamide gels. Proteins were transferred to poly vinylidene
difluorid membrane, and incubated with anti-PKC delta (Cell
signaling), anti-phospho PKC delta (Thr505, Cell Signaling), anti-
phospho PKC alpha/beta2 (Thr638/641, Cell Signaling), anti-
PKC alpha (Cell signalling), anti-PKC beta2 (Santa Cruz), or anti-
alpha tubulin (Dianova) overnight at 4uC. Bound antibodies was
visualized by using horseradish peroxidase (HRP)-conjugated sheep
anti-mouse or donkey anti-rabbit antibody (both Amersham).
Preparation of Triton-soluble and Triton-insoluble
fractions
Cell pellets were resuspended in 1.0% Triton X-100, 50 mM
HEPES, pH 7.4, 5 mM EGTA, 5 mM MgCl2, 30% glycerol,
0.5 mM dithiothreitol (DTT), 100 mM NaCl, and Complete
Protease Inhibitor Cocktail Tablet (Roche), and incubated on ice
for 20 min. Aftercentrifugation (15,000G,15 min.),thetop fraction
was collected as the noncytoskeletal (Triton-soluble, TS) fraction.
The cytoskeletal (Triton-insoluble, TI) fraction was isolated by
sonication (output 565 s) in the same buffer without Triton X-100.
RNA isolation and RT-PCR analyses
Total RNAs from EPCs and rat CM were isolated by using
TRIzol (Invitrogen). RNA was subjected to RT-PCR by using
SuperScript First Strand Synthesis System (Invitrogen). Human
specific primers were used as following: troponin T (59-GAAGAA-
GAAGAGGAAGCAAAGGAG-39/59-TCCTTCTCCCGCTCA-
TTCC-39), GAPDH (59-GAAGGTGAAGGTCGGAGTC-39/59-
GAAGATGGTGATGGGATTTC-39), alpha myosin heavy chain
(59-GTCCCGGCAGCTAGAGGA-39/59-CCTCTGTCTCCT-
CCTCGTAC-39).
Statistical analysis
Data are expressed as mean6SEM. Unpaired two-tailed
students t-test (to compare 2 groups) or ANOVA ($3 groups)
were used for the comparison between groups based on the
original data.
Supporting Information
Figure S1
Found at: doi:10.1371/journal.pone.0005765.s001 (2.74 MB TIF)
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